SCHEMBL257398

SCHEMBL257398

COC(=O)c1cccc(C(=O)c2ccccc2)c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.55
SLC6A3 Q01959 1/20 0.54
KDM4E B2RXH2 4/20 0.51
POLB P06746 2/20 0.51
ATM Q13315 1/20 0.51
LMNA P02545 2/20 0.50
ALDH1A1 P00352 3/20 0.49
HSD17B10 Q99714 2/20 0.49
CFTR P13569 1/20 0.49
AKR1C3 P42330 2/20 0.48
MAPT P10636 4/20 0.47
ALOX15 P16050 2/20 0.47
MYC P01106 2/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
GAA P10253 2/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10780170 0.88 LMNA (0.50) TSHRSLC6A3KDM4EPOLBATM
SCHEMBL28000 0.85 TSHR (0.63) TSHRSLC6A3KDM4EPOLBATM
SCHEMBL29363206 0.85 TSHR (0.63) TSHRSLC6A3KDM4EPOLBATM
SCHEMBL27840685 0.85 TSHR (0.63) TSHRSLC6A3KDM4EPOLBATM
SCHEMBL30692319 0.85 AKR1C3 (0.59) POLBATMLMNAALDH1A1AKR1C3
SCHEMBL3511612 0.85 LMNA (0.59) TSHRSLC6A3KDM4EPOLBATM
Water SCHEMBL27735757 0.84 TSHR (0.61) TSHRSLC6A3KDM4EPOLBATM
Benzophenone SCHEMBL29531226 0.84 TSHR (0.61) TSHRSLC6A3KDM4EPOLBATM
SCHEMBL8755551 0.84 TSHR (0.61) TSHRSLC6A3KDM4EPOLBATM
SCHEMBL7041350 0.83 TSHR (0.55) TSHRSLC6A3KDM4EPOLBATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104854507-A Photocurable composition and device including barrier layer formed from the composition CHEIL IND INC 2015-08-19 CN disclosed
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 TSHR 914/4885SLC6A3 3602/4885KDM4E 2413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.